Alpha Centric Advisors LLC 2seventy Bio, Inc. Transaction History

Alpha Centric Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$3.14 - $11.2 $1.5 Million - $5.35 Million	477,500 Added 265.28%	657,500 $2.58 Million
Q2 2023 Aug 08, 2023	SELL	$8.45 - $12.48 $1.04 Million - $1.53 Million	-122,500 Reduced 40.5%	180,000 $1.82 Million
Q1 2023 May 12, 2023	BUY	$9.21 - $14.98 $1.13 Million - $1.84 Million	122,500 Added 68.06%	302,500 $3.09 Million
Q4 2022 Feb 07, 2023	BUY	$8.57 - $17.0 $968,410 - $1.92 Million	113,000 Added 168.66%	180,000 $1.69 Million
Q3 2022 Nov 08, 2022	BUY	$12.56 - $17.54 $715,920 - $999,780	57,000 Added 570.0%	67,000 $975,000
Q4 2021 Feb 25, 2022	BUY	$13.77 - $42.56 $137,700 - $425,600	10,000 New	10,000 $256,000

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $150M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.